These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15387924)

  • 61. [Considerations on various aspects of water elimination in ascitogenous liver cirrhosis].
    GAVRILESCU S; STREIAN C; OCICA I
    Med Interna (Bucur); 1961 Jun; 13():933-45. PubMed ID: 13704051
    [No Abstract]   [Full Text] [Related]  

  • 62. Comments on the review article: Ascites in cirrhosis: a review of management and complications.
    Koulaouzidis A; Bhat S
    Neth J Med; 2008 Apr; 66(4):177; author reply 178. PubMed ID: 18424869
    [No Abstract]   [Full Text] [Related]  

  • 63. [New diuretics in ascites of the cirrhotic patient (dihydroflumethiazide, benzhydroflumethiazide)].
    PIZZUTO J; DIES F; RIVERA A
    Prensa Med Mex; 1960 Jul 30-Sep 30; 25():394-404. PubMed ID: 13736169
    [No Abstract]   [Full Text] [Related]  

  • 64. Evaluation of hernia repair operation in Child-Turcotte-Pugh class C cirrhosis and refractory ascites.
    Park JK; Lee SH; Yoon WJ; Lee JK; Park SC; Park BJ; Jung YJ; Kim BG; Yoon JH; Kim CY; Ha J; Park KJ; Kim YJ
    J Gastroenterol Hepatol; 2007 Mar; 22(3):377-82. PubMed ID: 17295770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Bacteremia caused by Neisseria subflava and neutrocytic ascites in a female patient with hepatic cirrhosis].
    Len O; de Otero J; Almirante B; Pigrau C; Planes AM; Pahissa A
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):334-5. PubMed ID: 8744381
    [No Abstract]   [Full Text] [Related]  

  • 67. [Chronic viral hepatitis: protocol proposal for the management of cirrhosis].
    Diaz-Brito V; Cardoso H; Sarmento A
    Acta Med Port; 2008; 21(2):179-92. PubMed ID: 18625097
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Complications of liver cirrhosis: oesophageal varices, ascites and hepato-cellular carcinoma].
    Troillet FX; Halkic N; Froehlich F; Moradpour D; Gonvers JJ; Denys A
    Rev Med Suisse; 2005 Jan; 1(3):249-50, 252-5. PubMed ID: 15770820
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Control of ascites in schistosomal cirrhosis with chlorothiazide. A report of 36 cases.
    CHOU HC; HUANGFU M
    Chin Med J; 1962 Apr; 81():246-50. PubMed ID: 13879204
    [No Abstract]   [Full Text] [Related]  

  • 70. Care of the cirrhotic patient.
    Grewal P; Martin P
    Clin Liver Dis; 2009 May; 13(2):331-40. PubMed ID: 19442922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Preliminary experiences with re-infusion of ascitic fluid, partially desalinated and concentrated with the artificial kidney].
    Amerio A; Leondeff J; Coratelli P; Mastrangelo F; Chiummo R; Trotta M
    Minerva Med; 1967 Jun; 58(45):2125-30. PubMed ID: 6028374
    [No Abstract]   [Full Text] [Related]  

  • 72. [Continous abdominal-venous ascites perfusion in decompensated liver cirrhosis].
    Dittrich H
    Langenbecks Arch Chir; 1966; 316():208-10. PubMed ID: 5979681
    [No Abstract]   [Full Text] [Related]  

  • 73. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].
    Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN
    Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
    Ainsworth MA; Nielsen OH
    Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
    [No Abstract]   [Full Text] [Related]  

  • 75. [Cation-exchange therapy of ascites in liver cirrhosis].
    FIEBIG W
    Klin Wochenschr; 1954 Mar; 32(9-10):193-6. PubMed ID: 13153077
    [No Abstract]   [Full Text] [Related]  

  • 76. [Investigations of cardiovascular disorders in patients with portal cirrhosis with ascites].
    VICIU E; ARSENESCU G; RUSSU M; DULGHERU C; BREASLA I; GHEORGHESCU B; TACORIAN S
    Med Interna (Bucur); 1961 Mar; 13():389-99. PubMed ID: 13781148
    [No Abstract]   [Full Text] [Related]  

  • 77. [FURTHER attempts at therapy of the ascites of liver cirrhosis].
    Rev Clin Esp; 1959 Jun; 73():362. PubMed ID: 13858245
    [No Abstract]   [Full Text] [Related]  

  • 78. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Obstructive sleep apnea: a complication in cirrhotic patients with ascites?
    Golpe R; Mateos A
    Am J Gastroenterol; 2005 Jun; 100(6):1421-3; author reply 1423; author reply 1423. PubMed ID: 15929781
    [No Abstract]   [Full Text] [Related]  

  • 80. Hepatolymphomania.
    Witte MH
    Hepatology; 2004 Nov; 40(5):1230; author reply 1230. PubMed ID: 15486979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.